Treatment approaches in atherosclerosis prevention highlight the need for diverse therapeutic groups and risk factor management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Otto Mayer (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: